![Parand Darou Pharma](https://www.pharmacompass.com/image/flap/parand-darou-desktop-headergif-12950.gif)
![Parand Darou Pharma](https://www.pharmacompass.com/image/flap/parand-darou-mobgif-20656.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/amylyx-buy-bankrupt-eigers-experimental-drug-treat-low-blood-sugar-2024-06-21/
https://www.prnewswire.com/news-releases/sentynl-therapeutics-announces-global-acquisition-of-zokinvy-lonafarnib-for-treatment-of-hutchinson-gilford-progeria-syndrome-from-eiger-biopharmaceuticals-302135968.html
https://www.biospace.com/article/eiger-files-for-bankruptcy-plans-to-shutter-operations-after-difficult-year/
https://endpts.com/eiger-files-for-bankruptcy-and-will-wind-down-operations-after-years-of-setbacks/
https://www.globenewswire.com/news-release/2024/04/01/2855277/0/en/Eiger-BioPharmaceuticals-Files-for-Voluntary-Chapter-11-Protection.html
https://www.prnewswire.com/news-releases/eiger-and-partner-anges-receive-approval-for-zokinvy-lonafarnib-for-hutchinson--gilford-progeria-syndrome-and-processing-deficient-progeroid-laminopathies-in-japan-302038919.html
https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-inc-announces-1-for-30-reverse-stock-split-302026018.html
https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-reports-third-quarter-2023-financial-results-and-provides-business-update-301983997.html
https://www.reuters.com/business/healthcare-pharmaceuticals/eiger-discontinue-hepatitis-drug-study-2023-09-12/
https://www.prnewswire.com/news-releases/eiger-biopharmaceuticals-to-present-at-hc-wainwright-25th-annual-global-investment-conference-301918284.html